Click Here To Speed Genetic Science

It's no secret that many disorders, such as coronary artery disease and early-onset Parkinson's, have a genetic component. But figuring out which genes are responsible has been difficult, because doctors can't collect blood samples from enough people to be able to link symptoms to disease-causing genes. Dr. Hugh Y. Rienhoff Jr., founder and chief executive officer of biotech company DNA Sciences, based in Mountain View, Calif., thinks he can remedy that by using the Web to speed up patient recruitment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.